Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2012-11-15

FDA Approved: ACUVAIL — Supplemental Application (Allergan, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for ACUVAIL (ketorolac tromethamine) from Allergan, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ACUVAIL (ketorolac tromethamine)

Snippet

SUPPL AP for ACUVAIL (KETOROLAC TROMETHAMINE)